Mitochondrial morphogenesis, distribution, and parkinson disease: Insights from PINK1

Journal of Neuropathology and Experimental Neurology

Volumn 68, Issue 9, 2009, Pages 953-963

  Yang, Yufeng ^a,b   Lu, Bingwei ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Drosophila; Mitochondria; Parkinson disease; PINK 1

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA SYNUCLEIN; ATP13A2 PROTEIN; DJ 1 PROTEIN; FUNGICIDE; GUANOSINE TRIPHOSPHATASE; HEAT SHOCK PROTEIN; HERBICIDE; HTRA SERINE PEPTIDASE 2; IRON; LEUCINE RICH REPEAT KINASE 2; MANGANESE; MITOCHONDRIAL DNA; MITOFUSIN 1; MITOFUSIN 2; PARKIN; PEPTIDASE; PESTICIDE; PROTEIN; PROTEIN KINASE; PTEN INDUCED PUTATIVE KINASE 1; SERINE PROTEINASE OMI; UNCLASSIFIED DRUG;

APOPTOSIS; CELL ENERGY; CELL FUNCTION; CELL MOTILITY; CELLULAR DISTRIBUTION; DEGENERATIVE DISEASE; DROSOPHILA; ENDOSOME; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; GENE CONTROL; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; HEREDITY; HUMAN; IN VITRO STUDY; LEWY BODY; LYSOSOME; MITOCHONDRION; MORPHOGENESIS; NERVE CELL; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; TRANSPORT VESICLE;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MITOCHONDRIA; PARKINSON DISEASE; PROTEIN KINASES;

EID: 70349198009     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181b2048c     Document Type: Review

References (81)

1. Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 1998;339:1044-1053
2. Lang AE, Lozano AM. Parkinson's disease. Second of two parts. N Engl J Med 1998;339:1130-1143
3. Bernheimer H, Birkmayer W, Hornykiewicz O, et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973;20:415-455
4. Langston JW, Ballard P, Tetrud JW, et al. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219:979-980
5. Ascherio A, Chen H, Weisskopf MG, et al. Pesticide exposure and risk for Parkinson's disease. Ann Neurol 2006;60:197-203 (Pubitemid 44182394)
6. Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003;302:819-22
7. Belin AC, Westerlund M. Parkinson's disease: A genetic perspective. FEBS J 2008;275:1377-83
8. Conway KA, Rochet JC, Bieganski RM, et al. Kinetic stabilization of the alpha-synuclein protofibril by a dopamineYalpha-synuclein adduct. Science 2001;294:1346-49
9. Orth M, Tabrizi SJ, Schapira AH, et al. Alpha-synuclein expression in HEK293 cells enhances the mitochondrial sensitivity to rotenone. Neurosci Lett 2003;351:29-32
10. Martin LJ, Pan Y, Price AC, et al. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 2006;26:41-50
11. Dauer W, Kholodilov N, Vila M, et al. Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A 2002;99:14524-29
12. LaVoie MJ, Ostaszewski BL, Weihofen A, et al. Dopamine covalently modifies and functionally inactivates parkin. Nat Med 2005;11: 1214-21
13. Greene JC, Whitworth AJ, Kuo I, et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci U S A 2003;100:4078-83
14. Palacino JJ, Sagi D, Goldberg MS, et al. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 2004;279: 18614-22
15. Muftuoglu M, Elibol B, Dalmizrak O, et al. Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov Disord 2004;19:544-48
16. Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004;304: 1158-60
17. Ibanez P, Lesage S, Lohmann E, et al. Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. Brain 2006;129:686-94
18. Unoki M, Nakamura Y. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 2001;20:4457-65
19. Gandhi S, Muqit MM, Stanyer L, et al. PINK1 protein in normal human brain and Parkinson's disease. Brain 2006;129:1720-31
20. Canet-Aviles RM, Wilson MA, Miller DW, et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci U S A 2004;101: 9103-8
21. Kim RH, Smith PD, Aleyasin H, et al. Hypersensitivity of DJ-1Ydeficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A 2005;102:5215-20
22. Yang Y, Gehrke S, Haque ME, et al. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylino-sitol 3-kinase/Akt signaling. Proc Natl Acad Sci U S A 2005;102: 13670-75
23. Clements CM, McNally RS, Conti BJ, et al. DJ-1, a cancer-and Parkinson's diseaseYassociated protein, stabilizes the antioxidant tran-scriptional master regulator Nrf2. Proc Natl Acad Sci U S A 2006;103: 15091-96
24. Mandemakers W, Morais VA, De Strooper B. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases. J Cell Sci 2007;120:1707-16
25. MacLeod D, Dowman J, Hammond R, et al. The familial parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 2006;52: 587-93
26. Imai Y, Gehrke S, Wang HQ, et al. Phosphorylation of 4-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J 2008;27:2432-43
27. Ramirez A, Heimbach A, Grundemann J, et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 2006;38:1184-91
28. Strauss KM, Martins LM, Plun-Favreau H, et al. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet 2005;14:2099-111
29. Kitada T, Pisani A, Porter DR, et al. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci U S A 2007;104:11441-46
30. Gautier CA, Kitada T, Shen J. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A 2008;105:11364-69
31. Yang Y, Gehrke S, Imai Y, et al. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by parkin. Proc Natl Acad Sci USA 2006;103:10793-98
32. Park J, Lee SB, Lee S, et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 2006;441:1157-61
33. Clark IE, Dodson MW, Jiang C, et al. Drosophila Pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 2006;441:1162-66
34. Yang Y, Ouyang Y, Yang L, et al. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci U S A 2008;105:7070-75
35. Poole AC, Thomas RE, Andrews LA, et al. The PINK1/parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci U S A 2008; 105:1638-43
36. Exner N, Treske B, Paquet D, et al. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 2007;27:12413-18
37. Silver IA, Erecinska M. Glucose-induced intracellular ion changes in sugar-sensitive hypothalamic neurons. J Neurophysiol 1998;79:1733-45
38. Okamoto K, Shaw JM. Mitochondrial morphology and dynamics in yeast and multicellular eukaryotes. Annu Rev Genet 2005;39:503-36
39. Chan DC. Mitochondria: Dynamic organelles in disease, aging, and development. Cell 2006;125:1241-52
40. Ono T, Isobe K, Nakada K, et al. Human cells are protected from mitochondrial dysfunction by complementation of DNA products in fused mitochondria. Nat Genet 2001;28:272-75
41. Chen H, Chomyn A, Chan DC. Disruption of fusion results in mi-tochondrial heterogeneity and dysfunction. J Biol Chem 2005;280: 26185-92
42. Benard G, Bellance N, James D, et al. Mitochondrial bioenergetics and structural network organization. J Cell Sci 2007;120:838-48
43. Parone PA, Da Cruz S, Tondera D, et al. Preventing mitochondrial fission impairs mitochondrial function and leads to loss of mitochondrial DNA. PLoS ONE 2008;3:e3257
44. Szabadkai G, Simoni AM, Chami M, et al. Drp-1Ydependent division of the mitochondrial network blocks intraorganellar Ca2+ waves and protects against Ca2+-mediated apoptosis. Mol Cell 2004;16:59-68
45. Stowers RS, Megeath LJ, Gorska-Andrzejak J, et al. Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein. Neuron 2002;36:1063-77
46. Guo X, Macleod GT, Wellington A, et al. The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 2005;47:379-93
47. Chada SR, Hollenbeck PJ. Nerve growth factor signaling regulates mo-tility and docking of axonal mitochondria. Curr Biol 2004;14:1272-76
48. Chang DT, Honick AS, Reynolds IJ. Mitochondrial trafficking to synapses in cultured primary cortical neurons. J Neurosci 2006;26: 7035-45
49. Chang DT, Reynolds IJ. Differences in mitochondrial movement and morphology in young and mature primary cortical neurons in culture. Neuroscience 2006;141:727-36
50. Sasaki S, Warita H, Abe K, et al. Impairment of axonal transport in the axon hillock and the initial segment of anterior horn neurons in transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol 2005;110:48-56
51. Weihofen A, Thomas KJ, Ostaszewski BL, et al. Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. Biochemistry 2009;48:2045-52
52. Misgeld T, Kerschensteiner M, Bareyre FM, et al. Imaging axonal transport of mitochondria in vivo. Nat Methods 2007;4:559-61
53. Miller KE, Sheetz MP. Axonal mitochondrial transport and potential are correlated. J Cell Sci 2004;117:2791-804
54. Rintoul GL, Bennett VJ, Papaconstandinou NA, et al. Nitric oxide inhibits mitochondrial movement in forebrain neurons associated with disruption of mitochondrial membrane potential. J Neurochem 2006;97: 800-6
55. Verhoeven K, Claeys KG, Zuchner S, et al. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 2006;129:2093-102
56. Detmer SA, Chan DC. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. J Cell Biol 2007;176:405-14
57. Chen H, McCaffery JM, Chan DC. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 2007;130:548-62
58. Detmer SA, Vande Velde C, Cleveland DW, et al. Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A. Hum Mol Genet 2008;17: 367-75
59. Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000;26:207-10
60. Davies VJ, Hollins AJ, Piechota MJ, et al. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum Mol Genet 2007;16:1307-18
61. Verstreken P, Ly CV, Venken KJ, et al. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuro-muscular junctions. Neuron 2005;47:365-78
62. Waterham HR, Koster J, van Roermund CW, et al. A lethal defect of mitochondrial and peroxisomal fission. N Engl J Med 2007;356: 1736-41
63. Li Z, Okamoto K, Hayashi Y, et al. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004;119:873-87
64. Santel A, Frank S. Shaping mitochondria: The complex posttranslational regulation of the mitochondrial fission protein DRP1. IUBMB Life 2008;60:448-55
65. Li H, Chen Y, Jones AF, et al. Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neurons. Proc Natl Acad Sci U S A 2008;105:2169-74
66. Frank S, Gaume B, Bergmann-Leitner ES, et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 2001;1:515-25
67. Petit A, Kawarai T, Paitel E, et al. Wildtype PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson diseaseYrelated mutations. J Biol Chem 2005;280:34025-32
68. Deng H, Jankovic J, Guo Y, et al. Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem Biophys Res Commun 2005;337:1133-38
69. Pridgeon JW, Olzmann JA, Chin LS, et al. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 2007;5:e172
70. Plun-Favreau H, Klupsch K, Moisoi N, et al. The mitochondrial protease HtrA2 is regulated by Parkinson's diseaseYassociated kinase PINK1. Nat Cell Biol 2007;9:1243-52
71. Whitworth AJ, Lee JR, Ho VM, et al. Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and parkin. Dis Model Mech 2008;1:168-74
72. Yun J, Cao JH, Dodson MW, et al. Loss-of function analysis suggests that Omi/HtrA2 is not an essential component of the PINK1/PARKIN pathway in vivo. J Neurosci 2008;28:14500-10
73. Karbowski M, Norris KL, Cleland MM, et al. Role of Bax and Bak in mitochondrial morphogenesis. Nature 2006;443:658-62
74. Liu QA, Shio H. Mitochondrial morphogenesis, dendrite development, and synapse formation in cerebellum require both Bcl-w and the glutamate receptor delta2. PLoS Genet 2008;4:e1000097
75. Kuroda Y, Mitsui T, Kunishige M, et al. Parkin enhances mitochondrial biogenesis in proliferating cells. Hum Mol Genet 2006;15:883-95
76. Ekstrand MI, Terzioglu M, Galter D, et al. Progressive parkinsonism in mice with respiratory-chainYdeficient dopamine neurons. Proc Natl Acad Sci U S A 2007;104:1325-30
77. Liang CL, Wang TT, Luby-Phelps K, et al. Mitochondria mass is low in mouse substantia nigra dopamine neurons: Implications for Parkinson's disease. Exp Neurol 2007;203:370-80
78. Hoepken HH, Gispert S, Morales B, et al. Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiol Dis 2007;25:401-11
79. Trimmer PA, Swerdlow RH, Parks JK, et al. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp Neurol 2000;162:37-50
80. Hirai K, Aliev G, Nunomura A, et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 2001;21:3017-23
81. Wang X, Su B, Siedlak SL, et al. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mito-chondrial fission/fusion proteins. Proc Natl Acad Sci U S A 2008;105: 19318-19323